JPRN-jRCT2080222464未知2 期
Safety assessment study of ET-743 in patients with translocation-related sarcomas
适应症
试验速览
- 阶段
- 2 期
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 19age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Any of translocation-related sarcomas histopathologically confirmed at the study site
- •Unresponsiveness or intolerability to the standard chemotherapy regimens
排除标准
- •Severe concurrent disease
研究者
相似试验
未知
2 期
Safety study of ET-743 in patients with translocation-related sarcomasJPRN-jRCT2080221811Taiho Pharmaceutical Co., Ltd.37
未知
2 期
Phase II study of ET-743 in patients with translocation-related sarcomasJPRN-jRCT2080221808Taiho Pharmaceutical Co., Ltd.74
已完成
不适用
Clinical Evaluation of Safety and Performance of the BackBeat Moderato System1000752110057166HypertensionNL-OMON40595BackBeat Medical, Inc.10
已完成
不适用
A Clinical Study for Evaluating the Safety of Excessive Consumption of Food containing Plant Extract -Open StudyoJPRN-UMIN000032114Oneness support Co., Ltd.15
已完成
不适用
A Clinical Study for Evaluating the Safety of Excessive Consumption of Food containing Pueraria Flower Extract -Open Studyo (Subjects under 30 of BMI)JPRN-UMIN000023476KSO Corporation50